Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Percutaneous Intramyocardial Septal Radiofrequency Ablation in Patients With Drug-Refractory Hypertrophic Obstructive Cardiomyopathy
JAMA Cardiol 2022 Mar 30;[EPub Ahead of Print], M Zhou, S Ta, RT Hahn, DH Hsi, MB Leon, R Hu, J Zhang, L Zuo, J Li, J Wang, B Wang, X Zhu, J Liu, Y Han, X Li, B Xu, L Zhang, L Hou, C Han, J Liu, L LiuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.